Trading in warrants series TO2 2018-2021 commences on October 12, 2018

BrainCool AB’s warrants of series TO2 2018-2021 will commence trading on Spotlight Stock Market on October 12, 2018. The warrants were issued in conjunction with the convertible notes of series KV2 2018-2019 on August 24, 2018. Terms of the warrants in brief:

-Series TO2 warrants will be listed for trading on Spotlight Stock Market on October 12, 2018.

-Holding of one (1) warrants of series TO2 entitle the holder to subscribe for one (1) new share at a price of 8,26 SEK.

-Subscription of shares based on the warrants may take place during the following periods: ·

-          19 March 2019 through 2 April 2019

-          18 September 2019 through 2 October 2019

-          19 March 2019 through 2 April 2020

-          19 September 2020 through 2 October 2020

-          17 March 2021 through 31 March 2021

-          17 September 2021 through 1 October 2021

-Holders of warrants series TO2 2018/2021 for a total value of SEK 500,000 or more may always exercise the warrants for subscription of shares, i.e. from the date of listing to and including October 1, 2021.

-Warrants of series TO2 have ISIN code SE0011762418.

For terms and conditions of the warrants, please visit BrainCool’s website:

http://www.braincool.se/investor-relations-2/ 

For more information

Martin Waleij - CEO                                                               
+46 - 733 -93 70 76                                                                                          
E-mail: martin.waleij@braincool.se                       

About BrainCool AB (publ)

BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. The company focuses on two business segments, Brain Cooling and Pain Management. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Spotlight Stock Market.